No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kura Oncology's Stock Sinks To US$8.94, But Insiders Sold Even Lower
LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $37
Jonathan Chang Recommends 'Buy' on Kura Oncology Amid Promising Ziftomenib Advancements in AML Treatment
Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Kura Oncology (KURA)
Cantor Fitzgerald Reiterates Overweight on Kura Oncologyto Overweight
Unlock the Full List